120 related articles for article (PubMed ID: 38428827)
1. Proliferation and migration of PC-3 prostate cancer cells is counteracted by PPARγ-cladosporol binding-mediated apoptosis and a decreased lipid biosynthesis and accumulation.
Rapuano R; Riccio A; Mercuri A; Madera JR; Dallavalle S; Moricca S; Lupo A
Biochem Pharmacol; 2024 Apr; 222():116097. PubMed ID: 38428827
[TBL] [Abstract][Full Text] [Related]
2. Cladosporols A and B, two natural peroxisome proliferator-activated receptor gamma (PPARγ) agonists, inhibit adipogenesis in 3T3-L1 preadipocytes and cause a conditioned-culture-medium-dependent arrest of HT-29 cell proliferation.
Rapuano R; Ziccardi P; Cioffi V; Dallavalle S; Moricca S; Lupo A
Biochim Biophys Acta Gen Subj; 2021 Nov; 1865(11):129973. PubMed ID: 34352342
[TBL] [Abstract][Full Text] [Related]
3. The antiproliferative and proapoptotic effects of cladosporols A and B are related to their different binding mode as PPARγ ligands.
Zurlo D; Ziccardi P; Votino C; Colangelo T; Cerchia C; Dal Piaz F; Dallavalle S; Moricca S; Novellino E; Lavecchia A; Colantuoni V; Lupo A
Biochem Pharmacol; 2016 May; 108():22-35. PubMed ID: 26995279
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA PRRT3-AS1 silencing inhibits prostate cancer cell proliferation and promotes apoptosis and autophagy.
Fan L; Li H; Wang W
Exp Physiol; 2020 May; 105(5):793-808. PubMed ID: 32086850
[TBL] [Abstract][Full Text] [Related]
5. Cladosporol A, a new peroxisome proliferator-activated receptor γ (PPARγ) ligand, inhibits colorectal cancer cells proliferation through β-catenin/TCF pathway inactivation.
Zurlo D; Assante G; Moricca S; Colantuoni V; Lupo A
Biochim Biophys Acta; 2014 Jul; 1840(7):2361-72. PubMed ID: 24735796
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor gamma controls prostate cancer cell growth through AR-dependent and independent mechanisms.
Elix CC; Salgia MM; Otto-Duessel M; Copeland BT; Yoo C; Lee M; Tew BY; Ann D; Pal SK; Jones JO
Prostate; 2020 Feb; 80(2):162-172. PubMed ID: 31769890
[TBL] [Abstract][Full Text] [Related]
7. IL-6 and PPARgamma signalling in human PC-3 prostate cancer cells.
Pitulis N; Papageorgiou E; Tenta R; Lembessis P; Koutsilieris M
Anticancer Res; 2009 Jun; 29(6):2331-7. PubMed ID: 19528499
[TBL] [Abstract][Full Text] [Related]
8. The PPARγ ligand ciglitazone regulates androgen receptor activation differently in androgen-dependent versus androgen-independent human prostate cancer cells.
Moss PE; Lyles BE; Stewart LV
Exp Cell Res; 2010 Dec; 316(20):3478-88. PubMed ID: 20932825
[TBL] [Abstract][Full Text] [Related]
9. Thiazolidinediones regulate expression of cell cycle proteins in human prostate cancer cells via PPARgamma-dependent and PPARgamma-independent pathways.
Lyles BE; Akinyeke TO; Moss PE; Stewart LV
Cell Cycle; 2009 Jan; 8(2):268-77. PubMed ID: 19164938
[TBL] [Abstract][Full Text] [Related]
10. Cladosporol a stimulates G1-phase arrest of the cell cycle by up-regulation of p21(waf1/cip1) expression in human colon carcinoma HT-29 cells.
Zurlo D; Leone C; Assante G; Salzano S; Renzone G; Scaloni A; Foresta C; Colantuoni V; Lupo A
Mol Carcinog; 2013 Jan; 52(1):1-17. PubMed ID: 22025467
[TBL] [Abstract][Full Text] [Related]
11. Lycopene and the LXRα agonist T0901317 synergistically inhibit the proliferation of androgen-independent prostate cancer cells via the PPARγ-LXRα-ABCA1 pathway.
Yang CM; Lu YL; Chen HY; Hu ML
J Nutr Biochem; 2012 Sep; 23(9):1155-62. PubMed ID: 22137263
[TBL] [Abstract][Full Text] [Related]
12. 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes inhibit growth, induce apoptosis, and decrease the androgen receptor in LNCaP prostate cancer cells through peroxisome proliferator-activated receptor gamma-independent pathways.
Chintharlapalli S; Papineni S; Safe S
Mol Pharmacol; 2007 Feb; 71(2):558-69. PubMed ID: 17093136
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of lipogenesis and induction of apoptosis by valproic acid in prostate cancer cells via the C/EBPα/SREBP-1 pathway.
Pang B; Zhang J; Zhang X; Yuan J; Shi Y; Qiao L
Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(3):354-364. PubMed ID: 33471067
[TBL] [Abstract][Full Text] [Related]
14. Does the inhibition of c-myc expression mediate the anti-tumor activity of PPAR's ligands in prostate cancer cell lines?
Laidler P; Dulińska J; Mrozicki S
Arch Biochem Biophys; 2007 Jun; 462(1):1-12. PubMed ID: 17466258
[TBL] [Abstract][Full Text] [Related]
15. Thiazolidinediones/PPARγ agonists and fatty acid synthase inhibitors as an experimental combination therapy for prostate cancer.
Mansour M; Schwartz D; Judd R; Akingbemi B; Braden T; Morrison E; Dennis J; Bartol F; Hazi A; Napier I; Abdel-Mageed AB
Int J Oncol; 2011 Feb; 38(2):537-46. PubMed ID: 21170507
[TBL] [Abstract][Full Text] [Related]
16. Lycopene inhibits the proliferation of androgen-dependent human prostate tumor cells through activation of PPARγ-LXRα-ABCA1 pathway.
Yang CM; Lu IH; Chen HY; Hu ML
J Nutr Biochem; 2012 Jan; 23(1):8-17. PubMed ID: 21334870
[TBL] [Abstract][Full Text] [Related]
17. Troglitazone suppresses c-Myc levels in human prostate cancer cells via a PPARγ-independent mechanism.
Akinyeke TO; Stewart LV
Cancer Biol Ther; 2011 Jun; 11(12):1046-58. PubMed ID: 21525782
[TBL] [Abstract][Full Text] [Related]
18. RWJ-241947 (MCC-555), a unique peroxisome proliferator-activated receptor-gamma ligand with antitumor activity against human prostate cancer in vitro and in beige/nude/ X-linked immunodeficient mice and enhancement of apoptosis in myeloma cells induced by arsenic trioxide.
Kumagai T; Ikezoe T; Gui D; O'Kelly J; Tong XJ; Cohen FJ; Said JW; Koeffler HP
Clin Cancer Res; 2004 Feb; 10(4):1508-20. PubMed ID: 14977855
[TBL] [Abstract][Full Text] [Related]
19. Silencing of MEOX1 Gene Inhibits Proliferation and Promotes Apoptosis of LNCaP Cells in Prostate Cancer.
Zhu ZY; Wang XL; Li DP
Cancer Biother Radiopharm; 2019 Mar; 34(2):91-102. PubMed ID: 30543460
[TBL] [Abstract][Full Text] [Related]
20. Virtual screening and biological evaluation of PPARγ antagonists as potential anti-prostate cancer agents.
Almahmoud S; Elix CC; Jones JO; Hopkins CR; Vennerstrom JL; Zhong HA
Bioorg Med Chem; 2021 Sep; 46():116368. PubMed ID: 34433102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
